Ciprogen Drug Essay Example
Ciprogen Drug Essay Example

Ciprogen Drug Essay Example

Available Only on StudyHippo
Topics:
  • Pages: 6 (1543 words)
  • Published: November 18, 2016
  • Type: Research Paper
View Entire Sample
Text preview

Ciprofloxacin is a broad-spectrum antimicrobial drug from the fluoroquinolone group. It inhibits DNA gyrase and bacterial DNA synthesis, making it effective against various gram-negative bacteria such as Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Shigella spp., Salmonella spp., Neisseria meningitidis, and Neisseria gonorrhoeae. Some strains of Staphylococcus spp., Enterococcus spp., Campylobacter spp., Legionella spp., Mycoplasma spp., Chlamydia spp., and Mycobacterium spp. are also susceptible to ciprofloxacin. Furthermore, it can inhibit beta-lactamase-producing bacteria but does not work against Ureaplasma urealyticum or Clostridium difficile and has no effect on ciprofloxacin-resistant Nocardia asteroides. The impact of ciprofloxacin on Treponema pallidum remains insufficiently researched. In terms of pharmacokinetics, this drug is rapidly absorbed from the gastrointestinal tract with a bioavailability of 70% when taken orally. Food consumption minimally affects its absorption rate, while plasma protein binding ranges from 20%

...

to 40%.

Ciprogen is widely distributed in various tissues and body fluids. It can penetrate the cerebrospinal fluid, reaching concentrations of 10% in non-inflamed meninges and up to 37% in inflamed meninges. Moreover, it has high concentrations in bile. Ciprogen is excreted through both urine and bile. Doctors prescribe this medication for infectious-inflammatory diseases caused by microorganisms that are susceptible to ciprofloxacin. It effectively treats respiratory diseases, abdominal and pelvic organ diseases, bone and joint infections, skin infections, septicemia, as well as severe ENT organ infections.

The article discusses the treatment of postoperative infections and the prevention and treatment of infections in patients with weakened immune systems. It also mentions various conditions that can be treated locally, such as conjunctivitis, blepharoconjunctivitis, blepharitis, corneal ulcers, keratitis, keratoconjunctivitis, chronic dacryocystitis, and meybomity. Furthermore, it notes that the medication ca

View entire sample
Join StudyHippo to see entire essay

also be used for infectious eye lesions resulting from injury or contact with foreign bodies. Additionally, it highlights the use of the medication as preoperative prophylaxis in ophthalmic surgery. The recommended dosage is 250-750 mg taken orally twice a day.

The recommended treatment duration for Ciprogen ranges from 7 to 10 days or up to 4 weeks. When administered intravenously (IV), a dose of 200-400 mg is given twice daily. IV treatment typically lasts for 1-2 weeks, but can be prolonged if necessary. Although the IV dose can be given as a jet injection, it is preferable to administer it as a drip over a period of 30 minutes.

For topical application, the medication should be applied as 1-2 drops into the lower conjunctival sac of the affected eye every 1-4 hours. As the condition improves, the frequency of instillations can be reduced. The maximum daily oral dose for adults is 1.5 g; however, caution must be exercised due to potential side effects associated with Ciprogen.The digestive system can manifest symptoms like nausea, vomiting, diarrhea, and abdominal pain. It can also lead to increased levels of liver transaminases, alkaline phosphatase, LDH, and bilirubin. Pseudomembranous colitis is a potential result as well. The central nervous system (CNS) may be affected with symptoms including headache, dizziness, fatigue, insomnia, nightmares, hallucinations, fainting spells, and vision disorders.

The urinary system may experience several issues such as crystalluria, glomerulonephritis, dysuria, polyuria, albuminuria, hematuria, and a transient increase of serum creatinine.

The hemopoietic system can experience different changes, including eosinophilia, leukopenia, neutropenia, or variations in platelet count. Likewise, the cardiovascular system may be affected by tachycardia, cardiac arrhythmias, or hypotension.

justify;">Possible allergic reactions such as itching, urticaria, Quincke's edema, Stevens-Johnson syndrome, and arthralgia may occur. Additionally, candidiasis is an adverse reaction associated with the therapeutic effect.

IV injections can lead to local reactions such as pain and phlebitis. The application of eye drops may result in mild pain and conjunctival hyperemia in some cases. Other potential reactions include vasculitis. This medication should not be used during pregnancy, lactation (breastfeeding), childhood, and adolescence up to 15 years old, or if there is an increased sensitivity to ciprofloxacin and other drugs from the quinolone series, or a deficiency of glucose-6-phosphate dehydrogenase. It is also contraindicated for viral keratitis in ophthalmology. Certain limitations apply to its usage.

This condition may be called cerebral arteriosclerosis, cerebral circulatory disorder, mental illness, epilepsy, epileptic syndrome, or renal and/or hepatic insufficiency. It is important to note that using this medication during pregnancy and breastfeeding is not recommended. There have been no studies to establish the safety and effectiveness of ciprofloxacin in pregnant women. It is known that ciprofloxacin can cross the placenta and be excreted in breast milk. Experimental studies have shown that ciprofloxacin can cause arthropathy. However, when administered to rats and mice at doses six times higher than the normal daily human dose, no adverse effects on the fetus were observed.

Experiments on rabbits demonstrated that when ciprofloxacin was given orally at doses of 30 and 100 mg/kg, it led to gastrointestinal disturbances. This resulted in weight loss and an increase in miscarriages among female rabbits. Nevertheless, no teratogenic effects were observed. Alternatively, when ciprofloxacin was administered intravenously at a dose of 20 mg/kg, it did not

cause any toxic effects on the mother or the embryo, and no teratogenicity was observed.

If the benefits to the fetus outweigh the potential risks, ciprofloxacin can be used locally during pregnancy. According to the FDA, ciprofloxacin is classified as Category C in terms of its impact on the fetus. The drug is excreted in breast milk, so nursing mothers should consider their own health needs when deciding whether to continue medication or breastfeeding. It is uncertain how much of the drug passes into breast milk when using local forms of ciprofloxacin while breastfeeding. Patients with impaired kidney function should have their dosage adjusted accordingly. Elderly patients with conditions such as cerebral arteriosclerosis, cerebral circulatory disorders, epilepsy, or convulsive syndrome of unknown origin should use caution when taking ciprofloxacin.

During the treatment, it is advised to ensure that patients receive sufficient fluids. If a patient experiences persistent diarrhea, they should avoid taking Ciprofloxacin. When administering Ciprofloxacin intravenously along with barbiturates, it is crucial to monitor the patient's heart rate, blood pressure, and ECG. Additionally, it is necessary to keep track of the levels of urea, creatinine, and hepatic transaminases in the blood throughout the treatment period. Consumption of alcohol while on this medication may lead to a decrease in reactivity. It is strictly forbidden to inject Ciprofloxacin directly into the anterior chamber of the eye or subconjunctivally.

Ciprofloxacin should be used cautiously to reduce the risk of adverse reactions in patients with a history of central nervous system (CNS) issues, such as organic brain lesions, epilepsy, lowered convulsive threshold, severe brain atherosclerosis (which can cause circulatory problems and stroke), the elderly, or

those with significant impairment in renal and liver function (blood plasma concentration monitoring is necessary). Individuals who have had allergic reactions to fluoroquinolone derivatives may also react to ciprofloxacin.

During the treatment period, it is crucial to avoid sunlight and UV radiation, strenuous physical activity, and monitor drinking habits as well as urine pH. Crystalluria has been observed specifically in patients with alkaline urine (pH 7 or higher). To prevent crystalluria, it is also important to refrain from exceeding the recommended daily dosage, maintain proper fluid intake, and ensure urine acidity. If tendon pain or initial signs of tendovaginitis occur, treatment should be discontinued due to rare occurrences of tendon inflammation or rupture during fluoroquinolone treatment.

Ciprofloxacin can impair psychomotor reactions, so patients need to be cautious when operating dangerous machinery or driving vehicles. This impairment may be even worse if alcohol is consumed at the same time. It is important to rule out pseudomembranous colitis before using ciprofloxacin, especially in cases of severe diarrhea. When administering barbiturates intravenously, it is crucial to closely monitor cardiovascular function, including heart rate, blood pressure, and ECG. Ciprofloxacin should only be prescribed to individuals under 18 years old if other chemotherapeutic drugs are ineffective against the specific pathogen.

It is not recommended to inject the eye drops solution into the eye. It is advised to wait at least 5 minutes between injections of other ophthalmic medications. Ciprogen's activity is enhanced when used with beta-lactam antibiotics, aminoglycosides, vancomycin, clindamycin, or metronidazole. However, its absorption decreases when taken with sucralfate, bismuth preparations, antacids containing aluminum ions, magnesium or calcium, cimetidine, ranitidine,vitamin and mineral supplements, iron sulfate,zinc or

didanosine. If taking didanosine,it is best to consume it 2 hours before or 4 hours after these drugs.

Both probenecid and azlocillin have the same effect of increasing blood concentration and reducing clearance. As a result, levels of plasma caffeine, aminophylline, and theophylline are elevated, which can lead to an increased likelihood of experiencing side effects. Furthermore, when combined with warfarin and other oral anticoagulants, probenecid or azlocillin intensify their effect and cause prolonged bleeding time. Additionally, taking probenecid and azlocillin alongside NSAIDs enhances the risk of CNS excitability and convulsive reactions while also increasing the nephrotoxicity of cyclosporine.

Medications such as citrates, sodium bicarbonate, and carbonic anhydrase inhibitors have the ability to increase urine alkalinity. This can lead to a decrease in substance solubility and an elevated risk of crystalluria. When using Ciprofloxacin for infusion, it is possible to combine it with various solutions including 0.9% sodium chloride, Ringer's solution, Ringer lactate, 5% and 10% dextrose, 10% fructose solution, and a solution containing 5% dextrose with either 0.225% or 0.45% sodium chloride. However, caution should be exercised when combining Ciprofloxacin with solutions that possess a higher pH than Ciprogen in case of an emergency overdose.

Get an explanation on any task
Get unstuck with the help of our AI assistant in seconds
New